Related Experiment Videos
Differential regulation of E2F1, DP1, and the E2F1/DP1 complex by ARF
Abhishek Datta1, Alo Nag, Pradip Raychaudhuri
1Department of Biochemistry and Molecular Biology, University of Illinois at Chicago, Chicago, Illinois 60612, USA.
Abstract:
The tumor suppressor protein ARF inhibits MDM2 to activate and stabilize p53. Recent studies provided evidence for p53-independent tumor suppression functions of ARF. For example, it has been shown that ARF induces proteolysis of certain E2F species, including E2F1. In addition, ARF relocalizes E2F1 from the nucleoplasm to nucleolus and inhibits E2F1-activated transcription. Because DP1 is a functional partner of the E2F family of factors, we investigated whether DP1 is also regulated by ARF. Here we show that DP1 associates with ARF. Coexpression of ARF relocalizes DP1 from the cytoplasm to the nucleolus, suggesting that DP1 is also a target of the ARF regulatory pathways. Surprisingly, however, the E2F1/DP1 complex is refractory to ARF regulation. Coexpression of E2F1 and DP1 blocks ARF-induced relocalization of either subunit to the nucleolus. The E2F1/DP1 complex localizes in the nucleoplasm, whereas ARF is detected in the nucleolus, suggesting that ARF does not interact with the E2F1/DP1 complex. Moreover, we show that E2F1 is more stable in the presence of ARF when coexpressed with DP1. These results suggest that ARF differentially regulates the free and heterodimeric forms of E2F1 and DP1. DP1 is a constitutively expressed protein, whereas E2F1 is mainly expressed at the G(1)/S boundary of the cell cycle. Therefore, the E2F1/DP1 complex is abundant only between late G(1) and early S phase. Our results on the differential regulation E2F1, DP1, and the E2F1/DP1 complex suggest the possibility that ARF regulates the function of these cell cycle factors by altering the dynamics of their heterodimerization during progression from G(1) to S phase.
Insights
The tumor suppressor ARF protein regulates cell cycle factors E2F1 and DP1. ARF targets free DP1 and E2F1 but not their complex, impacting cell cycle progression.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Tumor Suppression
Background:
- The tumor suppressor protein ARF is known to inhibit MDM2, thereby activating and stabilizing p53.
- Emerging evidence suggests p53-independent tumor suppressive functions for ARF, including the induction of proteolysis and nucleolar relocalization of E2F1.
- ARF's ability to inhibit E2F1-activated transcription has been demonstrated.
Purpose of the Study:
- To investigate whether DP1, a functional partner of E2F family factors, is also regulated by ARF.
- To elucidate the interaction and regulatory mechanisms between ARF, E2F1, and DP1.
Main Methods:
- Co-expression studies to assess protein association and localization.
- Analysis of protein relocalization (cytoplasmic to nucleolar) upon co-expression.
- Investigation of E2F1 stability in the presence of ARF and DP1.
Main Results:
- DP1 associates with ARF, and ARF co-expression causes DP1 relocalization from the cytoplasm to the nucleolus.
- The E2F1/DP1 complex is refractory to ARF regulation; co-expression blocks ARF-induced relocalization of either subunit.
- ARF does not appear to interact with the E2F1/DP1 complex, which localizes in the nucleoplasm while ARF is in the nucleolus.
- E2F1 stability increases in the presence of ARF when coexpressed with DP1.
Conclusions:
- ARF differentially regulates free E2F1 and DP1 compared to the E2F1/DP1 heterodimer.
- The timing of E2F1/DP1 complex abundance (late G1 to early S phase) suggests ARF may control cell cycle progression by modulating heterodimerization dynamics.
- ARF's regulation of E2F1 and DP1 offers a potential mechanism for p53-independent tumor suppression.